人类乳头瘤病毒编码的microRNAs:宫癌发展的关键调节者
Sanae Bencheikh1,2, Hajar Lemriss3, Amal Souiri2
1Laboratory of Biology of Human Pathologies (BioPatH), Faculty of Sciences, Mohammed V University in Rabat, Rabat, Morocco.
RNA biology
|March 5, 2026
概括
人类乳头瘤病毒 (HPV) 编码病毒微RNA (v-miRNA) 调节宿主基因,促进子宫癌的发展. 这些v-miRNAs也是用于诊断和预后的有希望的生物标志物.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 人类乳头瘤病毒 (HPV) 与各种疾病有关,特别是宫癌.
- 细胞微RNAs (miRNAs) 是基因表达的关键调节者.
- 新兴研究突出显示HPV编码的病毒miRNAs (v-miRNAs) 具有重要的生物作用.
研究的目的:
- 提供HPV编码的miRNAs的最新审查.
- 详细介绍它们的分子点和在瘤发生过程中的作用.
- 讨论与HPV相关的宫癌的治疗策略和未来方向.
主要方法:
- 对HPV编码的miRNA研究的文献综述.
- 对v-miRNAs的验证分子标进行分析.
- 综合关于v-miRNA参与癌症途径的信息.
主要成果:
- HPV编码了调节病毒和宿主基因表达的v-miRNAs.
- 这些v-miRNAs影响瘤性途径,如细胞周期控制,细胞亡,免疫逃避,以及上皮-介质细胞过渡.
- v-miRNAs有助于病毒的持久性和恶性转变.
结论:
- 源自HPV的miRNA在HPV相关癌症的发展中起着至关重要的作用.
- v-miRNAs显示出作为宫癌诊断和预后的稳定和特定生物标志物的潜力.
- 需要进一步的研究和临床翻译,以miRNA为基础的治疗和诊断方法在精密瘤学.
相关概念视频
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs
24.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Induced Pluripotent Stem Cells
5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.7K
Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K
Mechanisms of Retrovirus-induced Cancers
7.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
Non-LTR Retrotransposons
13.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.6K


